# A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials

> **NCT06172374** · — · ACTIVE_NOT_RECRUITING · sponsor: **ReCode Therapeutics** · enrollment: 150 (estimated)

## Conditions studied

- Primary Ciliary Dyskinesia

## Interventions

- **GENETIC:** Sano Genetics Testing Kit

## Key facts

- **NCT ID:** NCT06172374
- **Lead sponsor:** ReCode Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-31
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06172374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06172374, "A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06172374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*